Clinical Trial Update: A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated entinostat in combination with nivolumab in patients with previously treated unresectable or metastatic cholangiocarcinoma and pancrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Entinostat (entinostat)
• nivolumab (nivolumab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Metastatic Cholangiocarcinoma, Cholangiocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2021-12-16